Literature DB >> 11563692

Interaction of alpha-lactalbumin with mini-alphaA-crystallin.

Y Sreelakshmi1, K K Sharma.   

Abstract

alphaA-Crystallin can function like a molecular chaperone. We have recently shown that residues 71-88 in alphaA-crystallin represent the "chaperone active site" of the protein. A peptide containing the sequence of alphaA-crystallin sequence DFVIFLDVKHFSPEDLTVK (mini alphaA-crystallin) by itself displays the antiaggregation property of alphaA-crystallin. We have prepared a complex of reduced alpha-lactalbumin and mini-alphaA-crystallin and investigated the nature, conformation, and properties of the complex by dynamic light scattering, HPLC analysis, CD spectroscopy, and fluorescence studies. Although mini-alphaA was able to prevent the precipitation of reduced alpha-lactalbumin, large aggregates (50-500 nm) of the complex were formed during the assay. Amino acid composition estimation revealed that alpha-lactalbumin and mini-alphaA-crystallin were present in 1:2 ratio in the aggregates. During our study significant red shift in the Trp fluorescence emission maximum and an increase in Bis-ANS binding to the mini alphaA-crystallin-bound alpha-lacatalbumin were observed. The CD spectra of the complex showed a significant loss of alpha-helical content but the beta-sheet content appeared to be less affected, indicating the molten-globule state of the reduced lactalbumin in the complex. These data show that the active site of alphaA-crystallin by itself can maintain a significantly denatured and unfolded protein in soluble form.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11563692     DOI: 10.1023/a:1011077307262

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  11 in total

1.  A small heat shock/alpha-crystallin protein from encysted Artemia embryos suppresses tubulin denaturation.

Authors:  Rossalyn M Day; Jagdish S Gupta; Thomas H MacRae
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

2.  The function of the beta3 interactive domain in the small heat shock protein and molecular chaperone, human alphaB crystallin.

Authors:  Joy G Ghosh; Marcus R Estrada; Scott A Houck; John I Clark
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

Review 3.  Alpha-crystallin-derived peptides as therapeutic chaperones.

Authors:  Murugesan Raju; Puttur Santhoshkumar; K Krishna Sharma
Journal:  Biochim Biophys Acta       Date:  2015-07-02

4.  Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone.

Authors:  Puttur Santhoshkumar; Krishna K Sharma
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

5.  Identification and characterization of a copper-binding site in αA-crystallin.

Authors:  Murugesan Raju; Puttur Santhoshkumar; T Michael Henzl; K Krishna Sharma
Journal:  Free Radic Biol Med       Date:  2011-02-23       Impact factor: 7.376

6.  Cell-penetrating Chaperone Peptide Prevents Protein Aggregation And Protects Against Cell Apoptosis.

Authors:  Murugesan Raju; Puttur Santhoshkumar; K Krishna Sharma
Journal:  Adv Biosyst       Date:  2017-11-13

7.  αA-Crystallin-derived mini-chaperone modulates stability and function of cataract causing αAG98R-crystallin.

Authors:  Murugesan Raju; Puttur Santhoshkumar; K Krishna Sharma
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

8.  Multiple sites in αB-crystallin modulate its interactions with desmin filaments assembled in vitro.

Authors:  Scott A Houck; Andrew Landsbury; John I Clark; Roy A Quinlan
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

9.  Hydrophobic residues of melittin mediate its binding to αA-crystallin.

Authors:  Lisa M Ramirez; Alexander Shekhtman; Jayanti Pande
Journal:  Protein Sci       Date:  2019-12-18       Impact factor: 6.993

10.  Molecular mechanism of the chaperone function of mini-α-crystallin, a 19-residue peptide of human α-crystallin.

Authors:  Priya R Banerjee; Ajay Pande; Alexander Shekhtman; Jayanti Pande
Journal:  Biochemistry       Date:  2014-12-26       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.